Form 483

Carter BloodCare at Hulen Form 483, 2022-10-28

FDA issued a Form 483 to Carter BloodCare at Hulen on 2022-10-28 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Carter BloodCare at Hulen · Fort Worth, United States · Issued October 28, 2022

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Oct 2022
21 CFR 630.10(g)(2)

Donor's Acknowledgment

Cited by Decarlos A Gomez

28 Oct 2022
21 CFR 630.10(g)(2)

Donor's Acknowledgment

Cited by Decarlos A Gomez

28 Oct 2022
21 CFR 630.10(g)(2)(ii)

Donor's Acknowledgment - Exculpatory language

Cited by Decarlos A Gomez

28 Oct 2022
21 CFR 630.10(g)(2)(ii)

Donor's Acknowledgment - Exculpatory language

Cited by Decarlos A Gomez

Inspected site

CBCarter BloodCare at HulenFort Worth, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 630.10(g)(2)Cited across public-safe Form 483 observations2x
21 CFR 630.10(g)(2)(ii)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere